Invention Grant
- Patent Title: Canine parvovirus (CPV) virus-like particle (VLP) vaccines and uses thereof
-
Application No.: US15265545Application Date: 2016-09-14
-
Publication No.: US10080798B2Publication Date: 2018-09-25
- Inventor: Frederic David , Zahia Hannas-Djebbara , Herve Poulet , Jules Maarten Minke
- Applicant: MERIAL, INC.
- Applicant Address: US GA Duluth
- Assignee: MERIAL INC.
- Current Assignee: MERIAL INC.
- Current Assignee Address: US GA Duluth
- Agency: Merial Inc.
- Agent Judy Jarecki-Black; Richard Seeger
- Main IPC: A61K39/23
- IPC: A61K39/23 ; C07K14/005 ; C12N7/00 ; A61K39/135 ; A61K39/12 ; A61K39/00
Abstract:
The present invention encompasses canine parvovirus (CPV) vaccines or compositions. The vaccine or composition may be a vaccine or composition containing CPV virus-like particle (VLP), and a preparation method and a use thereof. The CPV VLPs provided by the invention are formed by the CPV VP2 protein. Further, the invention broadly encompasses vaccines comprising combinations of MLV and VLP, which are capable of overcoming MDA against a variety of pathogens, which infect a variety of different species.
Public/Granted literature
- US20170087244A1 Canine Parvovirus (CPV) Virus-like Particle (VLP) Vaccines and uses thereof Public/Granted day:2017-03-30
Information query
